‘Text/HTML’ of page ‘NRG-BN011: Second Chemotherapy Drug for Glioblastoma’
Frequently Asked Questions Below, you can find FAQs about clinical research and this particular clinical trial.
Read MoreContent Block Tag: NRG-BN011: Second Chemotherapy Drug for Glioblastoma
‘Text/HTML’ of page ‘NRG-BN011: Second Chemotherapy Drug for Glioblastoma’
Am I eligible for this study? If you over the age of 18 with a glioblastoma and you have not yet received treatment for your glioblastoma, you may be able to participate. Your healthcare team is the best source for information about your treatment options, including cancer clinical trials. Be sure to take this information to your doctor to […]
Read More‘Text/HTML’ of page ‘NRG-BN011: Second Chemotherapy Drug for Glioblastoma’
About This Study NRG-BN011 is a clinical study for people with a type of brain tumor called a glioblastoma that have not yet received treatment other than surgery for their disease. Participants in this trial will need to be tested to see if their tumor has a biomarker called “methylated” MGMT. A biomarker gives information […]
Read More‘Text/HTML’ of page ‘NRG-BN011: Second Chemotherapy Drug for Glioblastoma’
Clinical Studies FAQ
Read More‘Text/HTML’ of page ‘NRG-BN011: Second Chemotherapy Drug for Glioblastoma’
NRG-BN011 FAQ
Read More